Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

remedē System Therapy Study

NCT: NCT03884660 · ACTIVE_NOT_RECRUITING

NCT IDNCT03884660
StatusACTIVE_NOT_RECRUITING
Start Date2019-06-18
Completion2030-12-30
SponsorRespicardia, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this non-randomized post market study is to collect clinical data on the safety and effectiveness of the remedē System in a real-world setting.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑